Evidence map›Paper›PMID 33629211›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Methicillin-resistant Staphylococcus argenteus in the Netherlands: not a new arrival.

Leonie E A Bank, Thijs Bosch, Leo M Schouls, Annemarie J L Weersink, Sandra Witteveen, Petra F G Wolffs, Roel H T Nijhuis

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Accurately IdentifyingDiagnostics (Basel, Switzerland) · 2026
    Article
  2. Prosthetic Joint Infection Caused byInfection and drug resistance · 2026
    Article
  3. Article
  4. Article
  5. CaninePathogens (Basel, Switzerland) · 2022
    Article
  6. First Report of a Methicillin-Resistant, High-Level Mupirocin-ResistantFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leonie E A BankDepartment of Medical Microbiology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. leonie.bank@mumc.nl.ORCID http://orcid.org/0000-0001-9599-0315
Thijs BoschNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Leo M SchoulsNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Annemarie J L WeersinkDepartment of Medical Microbiology and Medical Immunology, Meander Medical Center, Amersfoort, The Netherlands.
Sandra WitteveenNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Petra F G WolffsDepartment of Medical Microbiology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
Roel H T NijhuisDepartment of Medical Microbiology and Medical Immunology, Meander Medical Center, Amersfoort, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Methicillin ResistanceHumansNetherlandsStaphylococcal InfectionsStaphylococcusWound Infection

Identifiers

PMID33629211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.